Literature DB >> 18612206

Power of genetic association studies in the presence of linkage disequilibrium and allelic heterogeneity.

Sheila A Fisher1, Cathryn M Lewis.   

Abstract

OBJECTIVES: The calculation of the power and sample size required for association studies is essential, particularly for follow-up of genome-wide association studies, where much genotyping is required to replicate the original finding and identify the true disease susceptibility mutation.
METHODS: In this paper, we derive equations for estimation of sample sizes for the transmission disequilibrium test (TDT) and for case-control studies, in the presence of allelic heterogeneity and indirect association - where the genotyped tagging SNP is in linkage disequilibrium (LD) with the true mutation. Using data from NOD2 and PTPN22, we show that the true sample sizes required to detect association may be incorrect when calculated under the assumption of a single mutation and complete LD with the genotyped marker.
RESULTS: The true sample sizes may be lower when allelic heterogeneity acts in a recessive model across mutations, or increased when mutations lie on different alleles of a common tagging SNP.
CONCLUSION: Calculating power and sample size under a range of realistic models of LD and allelic heterogeneity is essential to ensure that association studies have sufficient power to detect mutations. Copyright (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612206      PMCID: PMC2787185          DOI: 10.1159/000143404

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  30 in total

1.  Complexity and power in case-control association studies.

Authors:  J A Longmate
Journal:  Am J Hum Genet       Date:  2001-04-04       Impact factor: 11.025

2.  Effect of allelic heterogeneity on the power of the transmission disequilibrium test.

Authors:  S L Slager; J Huang; V J Vieland
Journal:  Genet Epidemiol       Date:  2000-02       Impact factor: 2.135

3.  A general and accurate approach for computing the statistical power of the transmission disequilibrium test for complex disease genes.

Authors:  W M Chen; H W Deng
Journal:  Genet Epidemiol       Date:  2001-07       Impact factor: 2.135

4.  On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles.

Authors:  Richard W Morris; Norman L Kaplan
Journal:  Genet Epidemiol       Date:  2002-10       Impact factor: 2.135

5.  Effect of mode of inheritance when calculating the power of a transmission/disequilibrium test study.

Authors:  M M Iles
Journal:  Hum Hered       Date:  2002       Impact factor: 0.444

6.  A haplotype-based analysis of the PTPN22 locus in type 1 diabetes.

Authors:  Suna Onengut-Gumuscu; Jane H Buckner; Patrick Concannon
Journal:  Diabetes       Date:  2006-10       Impact factor: 9.461

7.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

9.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Authors:  J Hampe; A Cuthbert; P J Croucher; M M Mirza; S Mascheretti; S Fisher; H Frenzel; K King; A Hasselmeyer; A J MacPherson; S Bridger; S van Deventer; A Forbes; S Nikolaus; J E Lennard-Jones; U R Foelsch; M Krawczak; C Lewis; S Schreiber; C G Mathew
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

10.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

Authors:  Andrew P Cuthbert; Sheila A Fisher; Muddassar M Mirza; Kathy King; Jochen Hampe; Peter J P Croucher; Silvia Mascheretti; Jeremy Sanderson; Alastair Forbes; John Mansfield; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

View more
  7 in total

1.  Defining the power limits of genome-wide association scan meta-analyses.

Authors:  Kay Chapman; Teresa Ferreira; Andrew Morris; Jennifer Asimit; Eleftheria Zeggini
Journal:  Genet Epidemiol       Date:  2011-09-15       Impact factor: 2.135

Review 2.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

3.  Failure to detect significant association between estrogen receptor-alpha gene polymorphisms and endometriosis in Japanese women.

Authors:  Yasunari Matsuzaka; Yukie Y Kikuti; Shun-ichiro Izumi; Kenichi Goya; Takahiro Suzuki; Li-yi Cai; Akira Oka; Hidetoshi Inoko; Jerzy K Kulski; Minoru Kimura
Journal:  Environ Health Prev Med       Date:  2012-01-06       Impact factor: 3.674

Review 4.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

5.  FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.

Authors:  Christian Wider; Justus C Dachsel; Alexandra I Soto; Michael G Heckman; Nancy N Diehl; Mei Yue; Sarah Lincoln; Jan O Aasly; Kristoffer Haugarvoll; John Q Trojanowski; Spiridon Papapetropoulos; Deborah Mash; Alex Rajput; Ali H Rajput; J Mark Gibson; Timothy Lynch; Dennis W Dickson; Ryan J Uitti; Zbigniew K Wszolek; Matthew J Farrer; Owen A Ross
Journal:  Mov Disord       Date:  2009-02-15       Impact factor: 10.338

6.  An evaluation of different meta-analysis approaches in the presence of allelic heterogeneity.

Authors:  Jennifer Asimit; Aaron Day-Williams; Lina Zgaga; Igor Rudan; Vesna Boraska; Eleftheria Zeggini
Journal:  Eur J Hum Genet       Date:  2012-02-01       Impact factor: 4.246

Review 7.  Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases.

Authors:  Anja A Kühl; Ulrike Erben; Lea I Kredel; Britta Siegmund
Journal:  Front Immunol       Date:  2015-12-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.